samedan logo
 
 
 
spacer
home > ebr > autumn 2002 > to clone or not to clone: is politics preventing progress?
PUBLICATIONS
European Biopharmaceutical Review

To Clone or Not to Clone: Is Politics Preventing Progress?

Although US President George W. Bush has made it very clear to the American public that he favours a total ban on human cloning - whether for research or for reproductive purposes - legislation to do so has yet to pass muster in the US Senate. The subject of human cloning and stem cell research is being hotly debated in the US while scientists in other countries, unhampered by the prospect of a governmental ban, are forging ahead. Opponents to cloning fear the ethical and moral implications while proponents are keen to find the scientific answers that may one day lead to cures for Alzheimer's, Parkinson's, juvenile diabetes and a number of other debilitating diseases. Will we run amuck with this intensely powerful technology or learn to use it to our best advantage?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By G. Steven Burrill, CEO of Burrill & Company

G. Steven Burrill is CEO of Burrill & Company, a San Francisco-based life sciences merchant bank. Mr Burrill currently serves on eight Boards of Directors including DepoMed (Amex: DMI) and Third Wave Technologies (NASDAQ: TWTI), and is Chairman of the Boards of Pyxis Genomics and Paradigm Genetics (NASDAQ: PDGM).
Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and co-ordinating the firm's services to clients in the biotechnology, life sciences, high technology and manufacturing industries worldwide.

spacer
G. Steven Burrill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ICON Releases Environmental, Social and Governance Report

ICON announced today the release of its 2020 Environmental, Social and Governance (ESG) Report.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement